QT Imaging (NASDAQ:QTI – Get Free Report) and ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.
Institutional & Insider Ownership
24.2% of QT Imaging shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 75.4% of QT Imaging shares are held by company insiders. Comparatively, 0.7% of ENDRA Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares QT Imaging and ENDRA Life Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QT Imaging | N/A | N/A | -19.75% |
| ENDRA Life Sciences | N/A | -204.78% | -153.48% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QT Imaging | 0 | 0 | 0 | 0 | N/A |
| ENDRA Life Sciences | 0 | 0 | 1 | 0 | 3.00 |
ENDRA Life Sciences has a consensus price target of $8.00, suggesting a potential upside of 8,520.69%. Given ENDRA Life Sciences’ higher probable upside, analysts plainly believe ENDRA Life Sciences is more favorable than QT Imaging.
Volatility and Risk
QT Imaging has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.
Earnings and Valuation
This table compares QT Imaging and ENDRA Life Sciences’ revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QT Imaging | N/A | N/A | -$4.03 million | N/A | N/A |
| ENDRA Life Sciences | N/A | N/A | -$10.06 million | ($1.26) | -0.07 |
Summary
QT Imaging beats ENDRA Life Sciences on 5 of the 8 factors compared between the two stocks.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About ENDRA Life Sciences
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
